Daily Judi

Daily Judi: Friday, December 2, 2022

Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

Reporter Rachana Pradhan of Kaiser Health News looks at the booming business of clinical trials, and how it has drawn the attention of private equity firms. She writes, "Getting a drug to market a few months sooner and for less expense than usual can translate into millions in profit for the manufacturer."

Fierce Biotech examines Elon Musk's recent promotions of Neuralink on Twitter. Musk stated that Neuralink's brain implant is six months away from human clinical trials.

Howard Johnson, of RBW Consulting, lists five recruitment trends for clinical trials, including hybrid models, innovation, and inclusion. (Clinical Leader)

Our Culture

“I work mainly with one CRO, and they thank us for being proactive, and for our precise attention. We get a lot of appreciation from their whole team as we help them with their deliverable.”

   –Jess, Program Manager

About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 168 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 Type II certified collaboration platform.

No tags found.

Stay up-to-date with whats happening

Some sub copy covering what weekly/monthly update sand news one can expect.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.